滋肾健脾法联合沙格列汀治疗成人隐匿性自身免疫性糖尿病临床观察
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:

广东省中医药局课题(20141039)


Clinical Observation of Spleen-En forcing and Kidney-Nou rishing Method Combined with Glisamu ride for Latent Autoimmune Diabetes in Adults
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察滋肾健脾法联合沙格列汀治疗成人隐匿性自身免疫性糖尿病(LADA)患者的临床效果。方法:将90例脾肾两虚证LADA患者随机分为3组各30例,对照组予胰岛素治疗,沙格列汀对照组予胰岛素联合沙格列汀片治疗,中西医结合治疗组予胰岛素、沙格列汀片及脾肾方治疗,均干预36周。分别于治疗前、治疗12周后、治疗24周后、治疗36周后检测糖化血红蛋白、空腹C肽、胰高血糖素样肽-1(GLP-1)、胰高血糖素水平。结果:治疗24周后,3组糖化血红蛋白水平均较治疗前下降,差异均有统计学意义( P <0.05);治疗36周后,中西医结合治疗组的糖化血红蛋白水平低于对照组、沙格列汀对照组,差异均有统计学意义( P <0.05)。治疗12周后,3组空腹C肽水平均较治疗前增加,差异均有统计学意义( P <0.05);而相对于同组治疗12周后的C肽水平,沙格列汀对照组及中西医结合治疗组治疗24周后的C肽水平均增加,差异均有统计学意义( P <0.05);治疗36周后,沙格列汀对照组及中西医结合治疗组的C肽水平均较治疗24周后上升,差异均有统计学意义( P <0.05),且较同时间的对照组C肽水平升高,差异均有统计学意义( P <0.05),中西医结合治疗组C肽水平高于沙格列汀对照组,差异有统计学意义( P <0.05)。治疗24周后,沙格列汀对照组和中西医结合治疗组的GLP-1水平较治疗前与对照组同期增高,差异均有统计学意义( P <0.05);治疗36周后,中西医结合治疗组的GLP-1水平高于沙格列汀对照组与对照组,差异均有统计学意义( P <0.05),沙格列汀对照组及中西医结合治疗组的胰高血糖素均较治疗前下降,差异均有统计学意义( P <0.05)。结论:以滋肾健脾法联合沙格列汀可明显提高LADA患者的GLP-1、C肽水平,并可能通过抑制α细胞,减少胰高血糖素分泌,有利于β细胞恢复功能,有望缓解LADA的自然病程,值得进一步研究。

    Abstract:

    Objective: To observe the clinical effect of spleen-enforcing and kidney-nourishing method com bined with glisamuride for patients with latent autoimmune diabetes in adults(LADA).Methods:Divided 90 cases of LADA patients with spleen and kidney deficiency syndrome into the control group,the control group of glisamuride and the treatment group of integrated Chinese and western medicine randomly,30 cases in each group.The controlgroup was given insulin,the control group of glisamuride received insulin com bined with glisamuride tablets,and the treatment group of integrated Chinese and western medicine was given insulin,glisamuride tablets as wellas Pishen prescription.The intervention in the three groups all lasted for 36 weeks.Detected the levels of glycosylated hemoglobin,fasting C-peptide,glucagon-like peptide-1(GLP-1)and glucagon before treatment and after 12, 24, and 36 weeks of treatment respectively.Results: After 24 weeks of treatment,the levels of glycosylated hemoglobin in the three groups were all decreased when compared with those before treatment,differences being significant( P <0.05).After 36 weeks of treatment,glycosylated hemoglobin level in the treatment group of integrated Chinese and western medicine was lower than those in the control group and the controlgroup of glisamuride,differences being significant( P <0.05).After 12 weeks of treatment,fasting C-peptide levels in the threegroups were all increased when compared with those before treatment,differences being significant( P <0.05).The C-peptide levels in the controlgroup of glisamuride and the treatment group of integrated Chinese and western medicine after 24 weeks of treatment were increased when compared with those in the same groups after 12 weeks of treatment,differences being significant( P <0.05).After 36 weeks of treatment,C-peptide levels in the controlgroup of glisamuride and the treatment group of integrated Chinese and western medicine were increased when compared with those after 24 weeks of treatment,differences being significant( P <0.05)and were higher than that in the control group during the same period,differences being significant( P <0.05).C-peptide level in the treatment group of integrated Chinese and western medicine was higher than that in the controlgroup of glisamuride,difference being significant( P <0.05).After 24 weeks of treatment,GLP-1 levels in the control group of glisamuride and the treatment group of integrated Chinese and western medicine were increased when compared with that in the controlgroup during the same period,differences being significant( P <0.05).After 36 weeks of treatment,GLP-1 level in the treatment group of integrated Chinese and western medicine was higher than those in the control group of glisamuride and the control group,differences being significant( P <0.05).Glucagon in the control group of glisamuride and the treatment group of integrated Chinese and western medicine were decreased when compared with those before treatment,differences being significant( P <0.05).Conclusion:The therapy of the formula of spleen-enforcing and kidney-nourishing method com bined with glisamuride can significantly increase the levels of GLP-1 and C-peptide in LADA patients and inhibitα cells from reducing glucagon secretion.Expected to alleviate the natural history of LADA,it is beneficial to the recovery ofβ cells function and is worthy of further study.

    参考文献
    相似文献
    引证文献
引用本文

唐奇志,潘伟钰,刘剑文,陈聪,张燕华,梁嘉朗,肖静.滋肾健脾法联合沙格列汀治疗成人隐匿性自身免疫性糖尿病临床观察[J].新中医,2018,50(9):88-91

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-09-04
  • 出版日期: